Your single-source laboratory solution. FISH Probe Library
Alphabetical List by Probe with Clinical Indication Probe Clinical Indication 1p36 (TP73)/19q13 (GLTSCR) 1q21 (CKS1B) 5q (CSF1R/RPS14) 7q (MDFIC) 13q14 (DLEU) 20q (PTPRT) 21q ALK ATM BCL2 BCL6 CBFB, inv(16) CCND1 (CYCLIN D1) CCND1/IgH, t(11;14) CDKN2A (p16) (9p21) CKS1B (1p/1q ) Centromere 4 Enumeration Probe Centromere 6 Enumeration Probe Centromere 7 Enumeration Probe Centromere 8 Enumeration Probe Centromere 9 Enumeration Probe Centromere 10 Enumeration Probe Centromere 12 Enumeration Probe Centromere 15 Enumeration Probe Centromere 17 Enumeration Probe DDIT3 (CHOP) EGFR ETV6/RUNX1 (TEL/AML), t(12;21) EWSR1 FGFR1 Follicular lymphoma, Oligodendroglioma AML, MDS AML, MDS, MPN, CLL, MDS, MPN MDS, MPN B-ALL (adult), AML, T-cell anaplastic lymphoma CLL B-ALL (adult and pediatric), AML, CML AML CLL, Mantle cell lymphoma, CLL, Mantle cell lymphoma, B-ALL (adult), Melanoma MDS, MPD, MPN MPN, CLL Myxoid/Round cell liposarcoma Glioma, B-ALL, iamp ALL Ewing sarcoma, PNET 1
Probe Clinical Indication FGFR3/IGH, t(4;14) FOXO1 (FKHR) HER2 IGH IGH/BCL2, t(14;18) IGH/MAF, t(14;16) IGH/MYC, t(8;14) MALT1, t(11;18) MECOM (EVI1) MET MYB MYC MYCN PDGFRA PDGFRB PML/RARA, t(15;17) PTEN RARA RB1 (13q14) RET ROS1 RREB1 RUNX1T1/RUNX1 (ETO/AML), t(8;21) SS18 (SYT) TCF3 (E2A) TCR TP53 (17p deletion) UroVysion XX/XY Alveolar rhabdomyosarcoma Breast, Gastric cancer B-cell lymphoma Burkitt lymphoma, High grade B-cell lymphoma B-ALL (adult and pediatric), AML Marginal zone lymphoma AML, MDS Melanoma Burkitt lymphoma, High grade B-cell lymphoma Neuroblastoma APL Glioma APL Retinoblastoma Melanoma AML Synovial sarcoma T-cell leukemia AML, CLL, MDS, Bladder cancer Bone marrow transplant *includes Multiple myeloma and MGUS 2
Hematology/Oncology Profiles Disease Probes Included B-ALL (Adult) B-ALL (Pediatric) AML CLL MDS MPN/CML MPN with Eosinophilia Multiple Myeloma Aggressive B-cell Lymphoma 21q Chromosome 6 MYC CDKN2A (p16) Centromere 4 Centromere 10 Centromere 17 ETV6/RUNX1, t(12;21) TCF3 (E2A) 5q 7q CBFB, inv(16) PML/RARA, t(15;17) RUNX1T1/RUNX1, t(8;21) 13q14 (DLEU) ATM (11q) CCND1/IGH, t(11;14)** Centromere 12 TP53 (17p) 5q 7q 20q Centromere 8 13q14 (DLEU) 20q CDKN2A (Centromere 9) Centromere 8 FGFR1 PDGFRA PDGFRB 13q14 (DLEU) CCND1/IGH, t(11;14) Centromere 7 Centromere 9 Centromere 15 CKS1B (1q21) FGFR3/IGH, t(4;14) IGH/MAF, t(14;16) TP53 (17p) BCL2 BCL6 MYC **used as differential 3
Solid Tumor Probes Disease Probe Breast Cancer HER2 Bladder Cancer UroVysion Colorectal Cancer Gastric Cancer Glioma Lung Cancer (Non-Small Cell) Melanoma Neuroblastoma Retinoblastoma EGFR HER2 1p/19q EGFR PTEN ALK MET RET ROS1 CCND1 Centromere 6 MYB RREB1 MYCN RB1 (13q14) Sarcomas Ewing Sarcoma Alveolar Rhabdomyosarcoma Synovial Sarcoma Myxoid/Round Cell Liposarcoma EWSR1 FOXO1 (FKHR) SS18 (SYT) DDIT3 (CHOP) 4
Probes Suitable for FFPE Specimens Probe Clinical Indication 1p36 (TP73)/19q13 (GLTSCR) ALK BCL2 BCL6 CBFB, inv(16) CCND1 (CYCLIN D1) CCND1/IgH, t(11;14) DDIT3 (CHOP) EGFR ETV6/RUNX1 (TEL/AML), t(12;21) EWSR1 FOXO1 (FKHR) HER2 IGH IGH/BCL2, t(14;18) IGH/MYC, t(8;14) MALT1, t(11;18) MET MYC MYCN PDGFRA PDGFRB PTEN RB1 (13q14) RET ROS1 SS18 (SYT) TCR XX/XY Follicular lymphoma, Oligodendroglioma, T-cell anaplastic lymphoma B-ALL (adult and pediatric), CML AML CLL, Mantle cell lymphoma, CLL, Mantle cell lymphoma, Myxoid/Round cell liposarcoma Glioma, B-ALL Ewing sarcoma, PNET Alveolar rhabdomyosarcoma Breast, Gastric cancer B-cell lymphoma Follicular lymphoma Burkitt lymphoma, High grade B-cell lymphoma B-ALL (adult and pediatric), AML Marginal zone lymphoma Burkitt lymphoma, High grade B-cell lymphoma Neuroblastoma Glioma Retinoblastoma Synovial sarcoma T-cell leukemia Bone marrow transplant Formalin-fixed, paraffin-embedded *includes Multiple myeloma and MGUS 5
Specimen Requirements Type Preferred Alternate Blood Optimal: 10 ml (adult) or 3-5 ml (pediatric) in green-top (heparin) tube Acceptable: Lavender-top (EDTA) tube Bone Marrow Optimal: 1-3 ml in green-top (heparin) tube Fixed-cell pellet from cytogenetic analysis Slides prepared from a cytogenetic analysis Fixed-cell pellet from cytogenetic analysis Acceptable: Lavender-top (EDTA) tube Slides prepared from a cytogenetic analysis Tissue Formalin-fixed, paraffin-embedded (FFPE) tissue block 4-5 unstained slides, cut to 4-5 microns thick, air-dried overnight Specimens should be maintained at room temperature. For more specific specimen requirements for individual tests, please refer to www.integratedoncology.com/test-menu. 6
Integrated Oncology your single-source laboratory solution. More than 490,000 tests performed on 225,000+ patients annually 1,600 contractual relationships with plans, payors, and other health care organizations across the US, some of which are on an exclusive basis Integrated with more than 700 electronic medical records (EMR) and practice management systems Menu of more than 450 genetic, pathology, IHC, and FISH tests, including 15 oncology-specific pharmacogenetic tests Staff of more than 75 pathologists, PhDs, and genetic counselors dedicated to oncology and familial cancer testing More than 65 oncology- and pathology-specific publications and presentations since 2013 Lab Locations Arizona Integrated Oncology 5005 South 40th Street Phoenix, AZ 85040 800-710-1800 Fax 800-481-4151 New York Integrated Oncology 521 West 57th Street, Sixth Floor New York, NY 10019 800-447-5816 Fax 212-258-2143 North Carolina LabCorp Center for Molecular Biology and Pathology 1912 Alexander Drive Research Triangle Park, NC 27709 800-345-4363 Fax 919-361-7798 Tennessee Integrated Oncology 201 Summit View Drive, Suite 100 Brentwood, TN 37027 800-874-8532 Fax 615-370-8074 access answers actions UroVysion is a registered trademark of Abbott Laboratories, Inc. 2017 Laboratory Corporation of America Holdings. All rights reserved. onc-017-v7-0917 L17326-0917-7 www.integratedoncology.com